Published in Curr Chem Genomics on February 25, 2008
Prolonged and tunable residence time using reversible covalent kinase inhibitors. Nat Chem Biol (2015) 1.77
14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol (2011) 1.38
The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc (2014) 1.31
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun (2014) 1.21
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. Proc Natl Acad Sci U S A (2012) 1.16
Ten things you should know about protein kinases: IUPHAR Review 14. Br J Pharmacol (2015) 1.06
The central role of EED in the orchestration of polycomb group complexes. Nat Commun (2014) 1.04
Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. Proc Natl Acad Sci U S A (2014) 1.02
Single-molecule analysis reveals self assembly and nanoscale segregation of two distinct cavin subcomplexes on caveolae. Elife (2013) 1.01
Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format. Curr Chem Genomics (2008) 0.99
HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun (2014) 0.97
Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases. Q Rev Biophys (2013) 0.93
A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. Nat Commun (2016) 0.92
A novel high throughput biochemical assay to evaluate the HuR protein-RNA complex formation. PLoS One (2013) 0.92
Identification of Small-Molecule Inhibitors of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels. J Biomol Screen (2015) 0.86
Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression. J Biomol Screen (2014) 0.85
Aqueous two-phase systems enable multiplexing of homogeneous immunoassays. Technology (Singap World Sci) (2014) 0.84
Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat Chem Biol (2017) 0.83
The application of modular protein domains in proteomics. FEBS Lett (2012) 0.82
Allosteric modulation and functional selectivity of G protein-coupled receptors. Drug Discov Today Technol (2013) 0.82
Externally sensitized deprotection of PPG-masked carbonyls as a spatial proximity probe in photoamplified detection of binding events. Photochem Photobiol Sci (2012) 0.81
Fluorescence anisotropy (polarization): from drug screening to precision medicine. Expert Opin Drug Discov (2015) 0.79
A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling. Biosensors (Basel) (2012) 0.79
Rapid mapping of interactions between Human SNX-BAR proteins measured in vitro by AlphaScreen and single-molecule spectroscopy. Mol Cell Proteomics (2014) 0.79
Understanding HIV-1 protease autoprocessing for novel therapeutic development. Future Med Chem (2013) 0.79
Role for human mediator subunit MED25 in recruitment of mediator to promoters by endoplasmic reticulum stress-responsive transcription factor ATF6α. J Biol Chem (2013) 0.79
A cell-free enzymatic activity assay for the evaluation of HIV-1 drug resistance to protease inhibitors. Front Microbiol (2015) 0.79
A homogenous luminescent proximity assay for 14-3-3 interactions with both phosphorylated and nonphosphorylated client peptides. Curr Chem Genomics (2008) 0.79
A novel high throughput 1536-well Notch1 γ -secretase AlphaLISA assay. Comb Chem High Throughput Screen (2013) 0.78
Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers. PLoS One (2015) 0.78
Characterization of EPPIN's semenogelin I binding site: a contraceptive drug target. Biol Reprod (2012) 0.77
A Bead-Based Proximity Assay for BRD4 Ligand Discovery. Curr Protoc Chem Biol (2015) 0.77
A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance. PLoS One (2016) 0.75
Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247. FASEB J (2014) 0.75
Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence. PLoS One (2016) 0.75
Epigenetic assays for chemical biology and drug discovery. Clin Epigenetics (2017) 0.75
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b. J Vis Exp (2016) 0.75
Nanomolar oligomerization and selective co-aggregation of α-synuclein pathogenic mutants revealed by single-molecule fluorescence. Sci Rep (2016) 0.75
AlphaScreen-based homogeneous assay using a pair of 25-residue artificial proteins for high-throughput analysis of non-native IgG. Sci Rep (2017) 0.75
Probes for monitoring regulated exocytosis. Cell Calcium (2017) 0.75
Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (1992) 12.18
Growth factor receptor tyrosine kinases. Annu Rev Biochem (1988) 8.67
Protein serine/threonine kinases. Annu Rev Biochem (1987) 8.42
Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet (2001) 5.00
Signalling by receptor tyrosine kinases. Annu Rev Biochem (1993) 4.11
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature (2002) 3.11
Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal Biochem (2003) 2.15
Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci U S A (1994) 2.02
Progress in high throughput SNP genotyping methods. Pharmacogenomics J (2002) 1.88
Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J Proteome Res (2006) 1.61
Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method. Clin Chem (1996) 1.40
A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors. J Biomol Screen (2002) 1.30
A high throughput screen to identify substrates for the ubiquitin ligase Rsp5. J Biol Chem (2005) 1.20
High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol (2003) 1.19
cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Discov (2004) 1.18
Homogeneous assays for single-nucleotide polymorphism typing using AlphaScreen. Genome Res (2001) 1.14
GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors. J Biomol Screen (2005) 0.97
Development of a versatile platform for nuclear receptor screening using AlphaScreen. J Biomol Screen (2003) 0.96
Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists. J Biomol Screen (2003) 0.96
Evaluation of different glutathione S-transferase-tagged protein captures for screening E6/E6AP interaction inhibitors using AlphaScreen. J Biomol Screen (2007) 0.94
A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma. J Biomol Screen (2007) 0.91
AlphaScreen kinase HTS platforms. Curr Med Chem (2004) 0.90
Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform. J Biomol Screen (2004) 0.89
A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology. J Biomol Screen (2003) 0.89
Bioluminescence resonance energy transfer as a screening assay: Focus on partial and inverse agonism. J Biomol Screen (2006) 0.89
Development of a high-throughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen ). J Biomol Screen (2003) 0.89
Homogeneous assays for adenosine 5'-monophosphate-activated protein kinase. Anal Biochem (2003) 0.87
A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP). J Biomol Screen (2002) 0.85
A sensitive, robust high-throughput electrochemiluminescence assay for rat insulin. J Biomol Screen (2004) 0.84
Identification of phosphorylation sites using microimmobilized metal affinity chromatography. Methods Enzymol (2005) 0.83
Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreenTM high-throughput screen. J Biomol Screen (2006) 0.83
Quantification of DNA using the luminescent oxygen channeling assay. Clin Chem (2000) 0.82
Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates. J Biomol Screen (2006) 0.81
A "mix and read" assay for insulin using fluorometric microvolume assay technology. Assay Drug Dev Technol (2003) 0.80
A PDZ domain-based assay for measuring HIV protease activity: assay design considerations. Protein Sci (2003) 0.79
A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors. J Biomol Screen (2002) 1.30
A high throughput screen to identify substrates for the ubiquitin ligase Rsp5. J Biol Chem (2005) 1.20
Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biol Chem (2005) 1.16
The current status of drug discovery against the human kinome. Assay Drug Dev Technol (2009) 1.14
Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening. Assay Drug Dev Technol (2007) 1.12
Drug discovery and the human kinome: recent trends. Pharmacol Ther (2011) 0.98
Development of a versatile platform for nuclear receptor screening using AlphaScreen. J Biomol Screen (2003) 0.96
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev Technol (2010) 0.93
Current Screens Based on the AlphaScreen Technology for Deciphering Cell Signalling Pathways. Curr Genomics (2009) 0.91
AlphaScreen kinase HTS platforms. Curr Med Chem (2004) 0.90
Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles. J Neurochem (2002) 0.87
Ligand binding assays in the 21st Century laboratory: platforms. AAPS J (2012) 0.85
Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4. J Biomol Screen (2011) 0.84
Photoproteins: important new tools in drug discovery. Assay Drug Dev Technol (2008) 0.83
Single-well monitoring of protein-protein interaction and phosphorylation-dephosphorylation events. Biochemistry (2010) 0.82
Biochemical clustering of monomeric GTPases of the Ras superfamily. Mol Cell Proteomics (2005) 0.82
Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates. J Biomol Screen (2006) 0.81
The use of immortalized cell lines in GPCR screening: the good, bad and ugly. Comb Chem High Throughput Screen (2008) 0.81
AlphaScreen-based characterization of the bifunctional kinase/RNase IRE1alpha: a novel and atypical drug target. J Biomol Screen (2010) 0.81
An overview of drug screening using primary and embryonic stem cells. Comb Chem High Throughput Screen (2008) 0.80
Phosphorylation of serine palmitoyltransferase long chain-1 (SPTLC1) on tyrosine 164 inhibits its activity and promotes cell survival. J Biol Chem (2013) 0.80
New insights into GPCR function: implications for HTS. Methods Mol Biol (2009) 0.79
Catalytic specificity of human protein tyrosine kinases revealed by Peptide substrate profiling. Curr Chem Genomics (2011) 0.77
Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors. Expert Opin Drug Discov (2010) 0.77
Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview. J Biomol Screen (2011) 0.77
Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay. J Biomol Screen (2008) 0.76
Integrated cell-based platform to study EGFR activation and transactivation. Assay Drug Dev Technol (2013) 0.75